Back to: our work | re-brand

Synagis, Protecting the ones we love.

Syangis® is used to treat Respiratory Syncytial Virus (RSV), a common infection that affects the lungs of premature babies. Origo was approached in developing new strategy, branding, and marketing to elevate awareness among healthcare professionals. Following our branding process, we developed an identity that would capture the attention of HCP's and new parents. We selected age-specific models to brand direct mailers, pediatric office literature, tracking forms, calendars and office folder packets. The strategy was applied to our direct mail campaign and was met with overwhelming success.